Citation: H. Morr, Respiratory distress syndrome - Epidemiology, economic significance and care structures in the case of chronic obstructive pulmonary disease, INTERNIST, 42(3), 2001, pp. 373
Authors:
Schneider, J
Morr, H
Velcovsky, HG
Weisse, G
Eigenbrodt, E
Citation: J. Schneider et al., Quantitative detection of Tumor M2-pyruvate kinase in plasma of patients with lung cancer in comparison to other lung diseases, CANCER DET, 24(6), 2000, pp. 531-535
Authors:
Gunther, A
Mosavi, P
Ruppert, C
Heinemann, S
Temmesfeld, B
Velcovsky, HG
Morr, H
Grimminger, F
Walmrath, D
Seeger, W
Citation: A. Gunther et al., Enhanced tissue factor pathway activity and fibrin turnover in the alveolar compartment of patients with interstitial lung disease, THROMB HAEM, 83(6), 2000, pp. 853-860
Authors:
Schneider, J
Velcovsky, HG
Morr, H
Katz, N
Neu, K
Eigenbrodt, E
Citation: J. Schneider et al., Comparison of the tumor markers tumor M2-PK, CEA, CYFRA 21-1, NSE and SCC in the diagnosis of lung cancer, ANTICANC R, 20(6D), 2000, pp. 5053-5058
Authors:
Gunther, A
Schmidt, R
Nix, F
Yabut-Perez, M
Guth, C
Rosseau, S
Siebert, C
Grimminger, F
Morr, H
Velcovsky, HG
Seeger, W
Citation: A. Gunther et al., Surfactant abnormalities in idiopathic pulmonary fibrosis, hypersensitivity pneumonitis and sarcoidosis, EUR RESP J, 14(3), 1999, pp. 565-573
Authors:
Lohmeyer, J
Friedrich, J
Grimminger, F
Maus, U
Tenter, R
Morr, H
Velcovsky, HG
Seeger, W
Rosseau, S
Citation: J. Lohmeyer et al., Expression of mucosa-related integrin alpha(E)beta(7) on alveolar T cells in interstitial lung diseases, CLIN EXP IM, 116(2), 1999, pp. 340-346